WHO approves China’s Covid-19 vaccine China National Pharmaceutical Group

The World Health Organization has approved the Covid-19 vaccine developed by Chinese state-owned company Sinopharm, unveiled its potential for global use, and supported a bid to play a leading role in the battle in Beijing. Pandemic..

The International Health Organization has recommended immediate use of the vaccine as part of the “Emergency Use List”. He said drug deployment would help alleviate the acute vaccine shortage in developing countries where more than a small part of the population could not be vaccinated.

Covid-19 Pandemic Details

However, approval was cautioned because the WHO said there were too few data to show whether the vaccine was effective for people over the age of 60.

Nonetheless, the WHO panel reviewing vaccines (experts in its strategic advisory group) concluded that preliminary data suggest that older subjects are likely to have gained some protection. The panel found no reason to believe that Shot was not as safe in a group of older people as it was in young demographics. Vaccine for all adults 18 years and older There was a 79% effect For prevention of symptomatological cases of Covid-19.

“The addition of this vaccine could rapidly accelerate access to the Covid-19 vaccine in countries seeking to protect healthcare workers and endangered people,” said WHO’s access to health products. Dr. Mariangela Shimao, Deputy Director in charge, said.

Soldiers will carry a box of Sinofarm vaccines in Skopje, North Macedonia, on April 30.


georgi licovski / Shutterstock

The shot looks like this Massive surge in Covid-19 cases in IndiaThe world’s largest vaccine maker, has overturned the terribly needed global supply of shots. Due to India’s export controls, WHO’s Covax program, which aims to vaccinate 20% of the population of developing countries, is struggling to get supplies.

The Chinese Covid-19 vaccine offers a relatively low level of protection compared to some foreign rivals. This is why China has joined other countries to consider vaccine mixing and matching as the key to overcoming multiple vaccination challenges at once. Illustration: Ksenia Shaikhutdinova

However, global healthcare experts have criticized the Chinese government and Chinese vaccine makers, including Sinopharm, for lack of transparency in clinical trials and efficacy data. China was able to control Covid-19 primarily, so Sinopharm had to conduct tests abroad in several different countries at once. WHO officials said the process was difficult. The old group remained lacking enough data.

Staff will test potential COVID-19 vaccine samples at the Sinopharm production plant in Beijing on April 11, 2020.


Zhang Yuwei / Associated Press

China National’s vaccine appears to be substantially less effective than the major Western coronavirus vaccines. Still, scientists claim its use when the number of Covid-19 cases worldwide is increasing at a rate of hundreds of thousands per day.Unlike the shot from

Pfizer Japan Inc..


Moderna Inc..

The Sinopharm vaccine does not need to be kept extremely cold and the small sticker on the vial will change color when the vaccine is exposed to excessive heat.

This vaccine is the sixth vaccine targeting Covid-19, which has been granted an emergency use authorization by WHO.

AstraZeneca PLC,

With Pfizer

Johnson & Johnson..

That’s all Inactivated virus vaccine It is approved. WHO is currently considering a second Chinese-made vaccine by Chinese pharmaceutical company Sinovac Biotech.

Write to Drew Hinsho And Chaoden

Copyright © 2020 DowJones & Company, Inc. all rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

WHO approves China’s Covid-19 vaccine China National Pharmaceutical Group

Source link WHO approves China’s Covid-19 vaccine China National Pharmaceutical Group

Back to top button